1,936
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Design and synthesis of 1,4-benzothiazine derivatives with promising effects against colorectal cancer cells

, , , , , & ORCID Icon | (Reviewing Editor) show all
Article: 1303909 | Received 27 Feb 2017, Accepted 03 Mar 2017, Published online: 31 Mar 2017

References

  • Ajani, O. O. (2012). Functionalized 1,4-Benzothiazine: A versatile scaffold with diverse biological properties. Archiv der Pharmazie, 345, 841–851. doi:10.1002/ardp.201200140
  • Al-Rashood, S. T., Aboldahab, I. A., Nagi, M. N., Abouzeid, L. A., Abdel-Aziz, A. A., Abdel-hamide, S. G., ... El-Subbagh, H. I. (2006). Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorganic & Medicinal Chemistry, 14, 8608–8621. doi:10.1016/j.bmc.2006.08.030
  • Best, R. B., Buchete, N. V., & Hummer, G. (2008). Are current molecular dynamics force fields too helical? Biophysical Journal, 95, L07–L09. doi:10.1529/biophysj.108.132696
  • Bollu, R., Palem, J. D., Bantu, R., Guguloth, V., Nagarapu, L., Polepalli, S., & Jain, N. (2015). Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids. European Journal of Medicinal Chemistry, 89, 138–146. doi:10.1016/j.ejmech.2014.10.051
  • Boyd, M. R. (1997). 2 The NCI in-vitro. Anticancer drug development guide: preclinical screening, clinical trials, and approval, 2, 23–42.10.1007/978-1-4615-8152-9
  • Chen, C. J., Song, B. A., Yang, S., Xu, G. F., Bhadury, P. S., Jin, L. H., ... Lu, P. (2007). Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives. Bioorganic & Medicinal Chemistry, 15, 3981–3989. doi:10.1016/j.bmc.2007.04.014
  • Cheng, Q., Oritani, T., Horiguchi, T., Yamada, T., & Mong, Y. (2000). Synthesis and biological evaluation of novel 9-functional heterocyclic coupled 7-deoxy-9-Dihydropaclitaxel analogue. Bioorganic & Medicinal Chemistry Letters, 10, 517–521. doi:10.1016/S0960-894X(00)00031-7
  • De Boer, E. C., De Jong, W. H., Steerenberg, P. A., Aarden, L. A., Tetteroo, E., De Groot, E. R., ... Ruitenberg, E. J. (1992). Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunology, Immunotherapy, 34, 306–312. doi:10.1007/BF01741551
  • Du, J., Yang, H., Zhang, D., Wang, J., Guo, H., Peng, B., Guo, Y., & Ding, J. (2010). Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab. The Journal of Immunology, 184, 1361–1368. doi:10.4049/jimmunol.0903178
  • Fringuelli, R., Schiaffella, F., Utrilla Navarro, M. P., Milanese, L., Santini, C., Rapucci, M., ... Riccardi, C. (2003). 1,4-Benzothiazine analogues and apoptosis: Structure–activity relationship. Bioorganic & Medicinal Chemistry, 11, 3245–3254. doi:10.1016/S0968-0896(03)00296-7
  • Fringuelli, R., Schiaffella, F., & Vecchiarelli, A. (2001). Antifungal and immunomodulating activities of 1,4-benzothiazine azole derivatives: Review. Journal of chemotherapy, 13, 9–14. doi:10.1179/joc.2001.13.1.9
  • Goyal, K., Gautam, N., Khandelwal, N., & Gautam, D. C. (2013). Synthesis and biological activity of substituted 4 H -1,4-benzothiazines, their sulfones, and ribofuranosides. Nucleosides, Nucleotides and Nucleic Acids, 32, 81–97. doi:10.1080/15257770.2013.765012
  • Janakiram, N. B., Indranie, C., Malisetty, S. V., Jagan, P., Steele, V. E., & Rao, C. V. (2008). Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Pharmaceutical Research, 25, 2151–2157. doi:10.1007/s11095-008-9582-7
  • Khairnar, B. J., Girase, P. S., & Chaudhari, B. (2013). A facile and green synthesis of “5-(3-methyl-7-substituted-4H-1, 4-benzothiazin-2-yl)-4-aryl-4H-1, 2, 4-triazole-3-thiols” under ultrasound irradiation. Oriental Journal Of Chemistry, 29, 285–289.10.13005/ojc/290145
  • Khan, M. T. H., Choudhary, M. I., Khan, K. M., & Rani, M. (2005). Structure–activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. Bioorganic & Medicinal Chemistry, 13, 3385–3395. doi:10.1016/j.bmc.2005.03.012
  • Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., & Vriend, G. (2004). Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Function, and Bioinformatics, 57, 678–683. doi:10.1002/prot.20251
  • Lagorce, D., Sperandio, O., Galons, H., Miteva, M. A., & Villoutreix, B. O. (2008). FAF-drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects. BMC Bioinformatics, 9, 396. doi:10.1186/1471-2105-9-396
  • Ramachandran, M., Nambikkairaj, B., Kumaran, K., De, A. K., & Kumar, G. R. (2013). In silico analysis of 3D-QSAR and molecular docking for Bcl-2 inhibitors to potential anticancer drug development. Journal of Applied Pharmaceutical Science, 3, 23–29. doi:10.7324/JAPS.2013.31005
  • Romanowski, M. J., Scheer, J. M., O’Brien, T., & McDowell, R. S. (2004). Crystal structures of a ligand-free and malonate-bound human caspase-1: Implications for the mechanism of substrate binding. Structure, 12, 1361–1371. doi:10.1016/j.str.2004.05.010
  • TH Khan, M. (2012). Novel tyrosinase inhibitors from natural resources–their computational studies. Current medicinal chemistry, 19, 2262–2272. doi:10.2174/092986712800229041
  • Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010). The global burden of cancer: Priorities for prevention. Carcinogenesis, 31, 100–110. doi:10.1093/carcin/bgp263
  • Vichai, V. & Kirtikara, K. (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols, 1, 1112–1116. doi:10.1038/nprot.2006.179
  • Zięba, A., Latocha, M., & Sochanik, A. (2013). Synthesis and in vitro antiproliferative activity of novel 12(H)-quino[3,4-b][1,4]benzothiazine derivatives. Medicinal Chemistry Research, 22, 4158–4163. doi:10.1007/s00044-012-0384-4